USMLE Prep - Medical Reference Library

Life‑Threatening Hyperkalemia — Membrane Stabilization, K+ Shift, and Removal

System: Nephrology • Reviewed: Sep 1, 2025 • Step 1Step 2Step 3

Synopsis:

ECG changes or K+ ≥6.0 mEq/L require immediate IV calcium for membrane stabilization, insulin/dextrose and beta‑agonist for intracellular shift, and measures to remove potassium (loop diuretics, binders, or dialysis). Identify and treat precipitating causes.

Key Points

  • Use the highest‑yield diagnostic test early; do not let testing delay time‑critical therapy.
  • Set objective targets (hemodynamic, neurologic, respiratory) and reassess frequently.
  • Plan definitive source control or reperfusion when indicated; document follow‑up and patient education.

Algorithm

  1. Place on monitor; obtain STAT ECG and BMP.
  2. If ECG changes or K+ ≥6.0 → give IV calcium immediately; repeat as needed.
  3. Give insulin + dextrose; consider nebulized albuterol; give sodium bicarbonate if severe acidosis.
  4. Start removal strategy: loop diuretic if diuresis possible; otherwise arrange urgent hemodialysis.
  5. Identify/stop offending meds; correct hypocalcemia/hypomagnesemia; address underlying AKI.
  6. Serial K+ checks every 1–2 h until stable; admit to monitored setting.

Clinical Synopsis & Reasoning

ECG changes or K+ ≥6.0 mEq/L require immediate IV calcium for membrane stabilization, insulin/dextrose and beta‑agonist for intracellular shift, and measures to remove potassium (loop diuretics, binders, or dialysis). Identify and treat precipitating causes.


Treatment Strategy & Disposition

Stabilize ABCs. Initiate guideline‑concordant first‑line therapy with precise dosing and continuous monitoring. Escalate to advanced/procedural interventions based on explicit failure criteria. Define ICU, step‑down, and ward disposition triggers; involve specialty teams early.


Epidemiology / Risk Factors

  • Risk varies by comorbidity and precipitants; see citations for condition‑specific data.

Investigations

TestRole / RationaleTypical FindingsNotes
12‑lead ECG + telemetryArrhythmia riskPeaked T waves, wide QRSRepeat after therapy
BMP, Mg, venous blood gasSeverity/acid‑baseHyperkalemia ± acidosisGuide bicarbonate use
Medication reviewIdentify causesACEi/ARB, K‑sparing diuretics, AKIStop contributors

Pharmacology

Medication/InterventionMechanismOnsetRole in TherapyLimitations
Calcium gluconate 10% 1 g IV (repeat PRN)Membrane stabilizationMinutesFor ECG changes/severe hyperkalemiaUse calcium chloride via central line
Regular insulin 10 units IV + 25 g dextroseShift K+ intracellularlyMinutesRe‑check K+ in 60 minUse dextrose first if euglycemic
Nebulized albuterol 10–20 mgβ2‑agonistMinutesAdjunct K+ shiftTachycardia; less effective on β‑blockers
Loop diuretic and isotonic fluidsRenal excretionHoursIf volume overloaded but with urine outputMonitor volume status
HemodialysisRemovalImmediateDefinitive in anuric/AKI or refractory casesCoordinate access/anticoagulation

Prognosis / Complications

  • Outcome depends on timeliness of diagnosis and definitive therapy; monitor for complications.

Patient Education / Counseling

  • Provide red‑flag education, adherence guidance, and explicit return precautions; arrange timely specialty follow‑up.

References

  1. UK Kidney Association Clinical Practice Guideline: Management of Hyperkalaemia in Adults (2023 update of 2020) — Link